LLY(Eli Lilly and Company) 的财务报表:医疗保健,综合制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $28.32B | $28.54B | $34.12B | $45.04B | $65.18B |
| 毛利润 | $21.01B | $21.91B | $27.04B | $36.62B | $54.13B |
| 营业利润 | — | — | — | — | — |
| 净利润 | $5.58B | $6.24B | $5.24B | $10.59B | $20.64B |
| 经营现金流 | $7.37B | $7.59B | $4.24B | $8.82B | $16.81B |
| 自由现金流 | $6.06B | $5.73B | $792.00M | $3.76B | $8.97B |
| 摊薄每股收益 | $6.12 | $6.90 | $5.80 | $11.71 | $22.95 |